Miangela M Laclé

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Immune Response

Top Venues

Cancer research

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Ann-Marie C Baker, Gayathri Nageswaran, Pablo Nenclares, Tahel Ronel, Kane Smith, Christopher Kimberley, Miangela M Laclé, Shreerang A Bhide, Kevin J Harrington, Alan A Melcher, Manuel Rodriguez, Benjamin M Chain, Trevor A Graham
FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA. Cancer research 84 (10) (2024)
Ann-Marie C Baker, Gayathri Nageswaran, Pablo Nenclares, Tahel Ronel, Kane Smith, Christopher Kimberley, Miangela M Laclé, Shreerang A Bhide, Kevin J Harrington, Alan A Melcher, Manuel Rodriguez, Benjamin M Chain, Trevor A Graham
FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA. Cancer research 84 (10) (2024)
Ann-Marie C Baker, Gayathri Nageswaran, Pablo Nenclares, Tahel Ronel, Kane Smith, Christopher Kimberley, Miangela M Laclé, Shreerang A Bhide, Kevin J Harrington, Alan A Melcher, Manuel Rodriguez, Benjamin M Chain, Trevor A Graham
FUME-TCRseq enables sensitive and accurate sequencing of the T-cell receptor from limited input of degraded RNA. Cancer research (2024)
Ann-Marie C Baker, Gayathri Nageswaran, Pablo Nenclares, Tahel Ronel, Kane Smith, Christopher Kimberley, Miangela M Laclé, Shreerang A Bhide, Kevin J Harrington, Alan A Melcher, Manuel Rodriguez, Benjamin M Chain, Trevor A Graham
FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA. Cancer research 84 (10) (2024)
Marinde J G Bond, Patricia A H Hamers, Geraldine R Vink, Wilhelmina M U van Grevenstein, Miangela M Laclé, Maarten van Smeden, Miriam Koopman, Jeanine M L Roodhart, Cornelis J A Punt, Anne E May
External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch population. Acta oncologica (Stockholm, Sweden) 61 (5) (2022)